INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY
Background Angiotensin receptor antagonists (ARB) improve outcomes in patients with systolic heart failure (HF), but may induce hyperkalemia (HK)and/or a worsening of renal function (WRF).
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E889-E889 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | E889 |
|---|---|
| container_issue | 13 |
| container_start_page | E889 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 59 |
| creator | Rossignol, Patrick Dobre, Daniela Gregory, Douglas Massaro, Joe Kiernan, Michael Konstam, Marvin Zannad, Faiez |
| description | Background Angiotensin receptor antagonists (ARB) improve outcomes in patients with systolic heart failure (HF), but may induce hyperkalemia (HK)and/or a worsening of renal function (WRF). |
| doi_str_mv | 10.1016/S0735-1097(12)60890-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1547373135</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109712608900</els_id><sourcerecordid>3380530111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2320-34a412940763ec8877f7a29bf0d04e7425ff9a1022c631646c364eff7b2e79343</originalsourceid><addsrcrecordid>eNqFkM2O0zAURi0EEmXgEZAssYFFhuufxMkGZKVuY8ikVeIKzcrKuI6UobRDPIM0j8BbkzQIJDasbOme7_j6Q-g1gUsCJHnfgGBxRCATbwl9l0CaQQRP0ILEcRqxOBNP0eIP8hy9COEWAJKUZAv0U1e5XqrK4OJ6q-rPslRXWmLdYFlhXS3VVlXnsSlULbdqZ3SOjazXyoxjXG6-YPVJ5UZvKryq5XwplKwNXkld7mqFt9Lo0dBcjoFGrwvTjOTmajJOpCxxY3bL65foWdcegn_1-7xAu5UyeRGVm7XOZRk5yihEjLec0IyDSJh3aSpEJ1qa3XSwB-4Fp3HXZS0BSl3CSMITxxLuu07cUC8yxtkFejN774bT9wcf7u3t6WE4jk9aEnPBBCMsHql4ptxwCmHwnb0b-m_t8GgJ2Kl1e27dTpVaQu25dQtj7uOc8-MXfvR-sMH1_uj8vh-8u7f7U_9fw4d_DO7QH3vXHr76Rx_-LmsDtTBLJgehZwOwXwtgkSU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547373135</pqid></control><display><type>article</type><title>INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY</title><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Rossignol, Patrick ; Dobre, Daniela ; Gregory, Douglas ; Massaro, Joe ; Kiernan, Michael ; Konstam, Marvin ; Zannad, Faiez</creator><creatorcontrib>Rossignol, Patrick ; Dobre, Daniela ; Gregory, Douglas ; Massaro, Joe ; Kiernan, Michael ; Konstam, Marvin ; Zannad, Faiez</creatorcontrib><description>Background Angiotensin receptor antagonists (ARB) improve outcomes in patients with systolic heart failure (HF), but may induce hyperkalemia (HK)and/or a worsening of renal function (WRF).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(12)60890-0</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Drug therapy ; Ethnicity ; Fractions ; Heart failure ; Internal Medicine ; Potassium</subject><ispartof>Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E889-E889</ispartof><rights>American College of Cardiology Foundation</rights><rights>2012 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 27, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109712608900$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids></links><search><creatorcontrib>Rossignol, Patrick</creatorcontrib><creatorcontrib>Dobre, Daniela</creatorcontrib><creatorcontrib>Gregory, Douglas</creatorcontrib><creatorcontrib>Massaro, Joe</creatorcontrib><creatorcontrib>Kiernan, Michael</creatorcontrib><creatorcontrib>Konstam, Marvin</creatorcontrib><creatorcontrib>Zannad, Faiez</creatorcontrib><title>INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY</title><title>Journal of the American College of Cardiology</title><description>Background Angiotensin receptor antagonists (ARB) improve outcomes in patients with systolic heart failure (HF), but may induce hyperkalemia (HK)and/or a worsening of renal function (WRF).</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Drug therapy</subject><subject>Ethnicity</subject><subject>Fractions</subject><subject>Heart failure</subject><subject>Internal Medicine</subject><subject>Potassium</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkM2O0zAURi0EEmXgEZAssYFFhuufxMkGZKVuY8ikVeIKzcrKuI6UobRDPIM0j8BbkzQIJDasbOme7_j6Q-g1gUsCJHnfgGBxRCATbwl9l0CaQQRP0ILEcRqxOBNP0eIP8hy9COEWAJKUZAv0U1e5XqrK4OJ6q-rPslRXWmLdYFlhXS3VVlXnsSlULbdqZ3SOjazXyoxjXG6-YPVJ5UZvKryq5XwplKwNXkld7mqFt9Lo0dBcjoFGrwvTjOTmajJOpCxxY3bL65foWdcegn_1-7xAu5UyeRGVm7XOZRk5yihEjLec0IyDSJh3aSpEJ1qa3XSwB-4Fp3HXZS0BSl3CSMITxxLuu07cUC8yxtkFejN774bT9wcf7u3t6WE4jk9aEnPBBCMsHql4ptxwCmHwnb0b-m_t8GgJ2Kl1e27dTpVaQu25dQtj7uOc8-MXfvR-sMH1_uj8vh-8u7f7U_9fw4d_DO7QH3vXHr76Rx_-LmsDtTBLJgehZwOwXwtgkSU</recordid><startdate>20120327</startdate><enddate>20120327</enddate><creator>Rossignol, Patrick</creator><creator>Dobre, Daniela</creator><creator>Gregory, Douglas</creator><creator>Massaro, Joe</creator><creator>Kiernan, Michael</creator><creator>Konstam, Marvin</creator><creator>Zannad, Faiez</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20120327</creationdate><title>INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY</title><author>Rossignol, Patrick ; Dobre, Daniela ; Gregory, Douglas ; Massaro, Joe ; Kiernan, Michael ; Konstam, Marvin ; Zannad, Faiez</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2320-34a412940763ec8877f7a29bf0d04e7425ff9a1022c631646c364eff7b2e79343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Drug therapy</topic><topic>Ethnicity</topic><topic>Fractions</topic><topic>Heart failure</topic><topic>Internal Medicine</topic><topic>Potassium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rossignol, Patrick</creatorcontrib><creatorcontrib>Dobre, Daniela</creatorcontrib><creatorcontrib>Gregory, Douglas</creatorcontrib><creatorcontrib>Massaro, Joe</creatorcontrib><creatorcontrib>Kiernan, Michael</creatorcontrib><creatorcontrib>Konstam, Marvin</creatorcontrib><creatorcontrib>Zannad, Faiez</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rossignol, Patrick</au><au>Dobre, Daniela</au><au>Gregory, Douglas</au><au>Massaro, Joe</au><au>Kiernan, Michael</au><au>Konstam, Marvin</au><au>Zannad, Faiez</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2012-03-27</date><risdate>2012</risdate><volume>59</volume><issue>13</issue><spage>E889</spage><epage>E889</epage><pages>E889-E889</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Background Angiotensin receptor antagonists (ARB) improve outcomes in patients with systolic heart failure (HF), but may induce hyperkalemia (HK)and/or a worsening of renal function (WRF).</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(12)60890-0</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E889-E889 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1547373135 |
| source | Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Cardiology Cardiovascular Drug therapy Ethnicity Fractions Heart failure Internal Medicine Potassium |
| title | INCIDENT HYPERKALEMIA IS AN INDEPENDENT THERAPEUTIC TARGET IN LOW EJECTION FRACTION HEART FAILURE PATIENTS. INSIGHTS FROM THE HEAAL STUDY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A35%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=INCIDENT%20HYPERKALEMIA%20IS%20AN%20INDEPENDENT%20THERAPEUTIC%20TARGET%20IN%20LOW%20EJECTION%20FRACTION%20HEART%20FAILURE%20PATIENTS.%20INSIGHTS%20FROM%20THE%20HEAAL%20STUDY&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Rossignol,%20Patrick&rft.date=2012-03-27&rft.volume=59&rft.issue=13&rft.spage=E889&rft.epage=E889&rft.pages=E889-E889&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(12)60890-0&rft_dat=%3Cproquest_cross%3E3380530111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547373135&rft_id=info:pmid/&rft_els_id=S0735109712608900&rfr_iscdi=true |